VFC Pediatric Vaccine Stockpile National Vaccine Advisory Committee October 23, 2007 Gregory S. Wallace, M.D., M.S., M.P.H. Chief, Vaccine Supply and Assurance.

Slides:

Advertisements

Similar presentations

Vaccines related epidemiology Programme design and policy options First EpiTrain course in Advanced Epidemiology Jurmala Latvia Hanna Nohynek.

Advertisements

Pandemic Influenza Vaccine Prioritization: Rationale and Process Pandemic Influenza Vaccine: Doses Administered and Safety Training Conference Tom Shimabukuro,

Implementing WA New State Exemption Requirements - Training for Schools and Child Cares/Preschools August XX, 2011 Preschool/Child Care Immunization Requirements.

Implementing WA New State Exemption Requirements - Training for Schools and Child Cares/Preschools August XX, 2011 Preschool/Child Care Immunization Requirements.

1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.

North Carolina Immunization Program (NCIP) Overview

Pandemic Influenza: Role and Responsibility of Local Public Health Richard M. Tooker, MD Chief Medical Officer Kalamazoo County Health and Community Services.

1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.

Registry Support of Immunization Program Activities Lance Rodewald, M.D. Director Immunization Services Division, NIP/CDC Bill Brand, M.P.H. Vice-President,

TM Prepared for your next patient. Review of Selected Changes to the 2012 Immunization Schedules H. Cody Meissner, MD Floating Hospital for Children Tufts.

Immunization Update SNOW Conference October 10, 2014 Trang Kuss, RN, MN, MPH Office of Immunization and Child Profile

The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.

Seasonal Influenza Vaccine Update Jeanne M. Santoli, MD, MPH National Center for Immunization and Respiratory Diseases Centers for Disease Control and.

1 Universal Immunization Against Rare Diseases  How much is a child’s life worth?  The individual vs society.

ATP NVAC PIWG Report Pandemic Influenza Antiviral Strategies and Priority Groups Andrew T. Pavia M.D. University of Utah.

Antiviral Stockpiling for Novel Strains of Influenza.

Economic Evaluation of Routine Childhood Immunization with DTaP, Hib, IPV, MMR and HepB Vaccines in the United States, 2001 Fangjun Zhou Health Services.

THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.

State Affiliate Challenge 1 South Dakota School Nurses Association Florida Association of School Nurses Delaware School Nurse Association.

Vaccines for Children Program Stockpile Status National Vaccine Advisory Committee February 4, 2010 Washington, DC Lance E Rodewald, MD Director, Immunization.

Needs and Recommendations for the United States Poliovirus Vaccine Stockpile Report of the Joint Working Group of the National Vaccine Advisory Committee.

New Vaccine Supply and Financing: A Case Study of Combination Vaccines in Developing Countries Viral Hepatitis Prevention Board Meeting Malta October 22-23,

Implementing New Vaccines and Vaccine Recommendations National Vaccine Advisory Committee Washington, DC September 26, 2006 Lance E. Rodewald, MD Director,

Texas Immunization Branch Influenza Update July 24 th, 2008.

Vaccine Supply Update Jeanne M. Santoli Vaccine Supply and Assurance Branch January 22, 2010.

U.S. Pandemic Influenza Preparedness and Response: Update & Progress Report “The pandemic influenza clock is ticking. We just don’t know what time it is.”

A Potential Influenza Pandemic: Possible Macroeconomic Effects and Policy Issues Julie Somers Congressional Budget Office Prepared for the Ninth Annual.

Implementation of HPV Vaccine Claire Hannan, MPH Executive Director, AIM NVAC September 26, 2006.

1 Flu Vaccine Shortage – Department of Veterans Affairs Experience Lawrence R. Deyton, MSPH, MD Chief, Public Health Department of Veterans Affairs.

Influenza Vaccination Update for Jeanne M. Santoli, MD, MPH Deputy Director, Immunization Services Division National Center for Immunization and.

State Health Agency Perspectives on the Implementation of New Vaccines Presentation to the National Vaccine Advisory Committee September 26, 2006 Calvin.

Polio Eradication -- Global Progress and Development of Post-Eradication Strategies: Implications for U.S. Stockpile and Outbreak Response Preparations.

July 19, 2005 Walter A. Orenstein, M.D. Professor of Medicine Director, Emory Vaccine Policy and Development Associate Director, Emory Vaccine Center Purchase.

PEDIATRIC VACCINE STOCKPILES A Status Report on the Pediatric Vaccine Stockpiles November 2005 Gregory S. Wallace, M.D., M.S., M.P.H. Chief, Program Support.

TM OPV Stockpiling in the United States Trudy V. Murphy, M.D. National Immunization Program Centers for Disease Control and Prevention February 5, 2003.

Planning for the Influenza Season: Will it be Rain, Shine, or Hurricane? National Vaccine Advisory Committee June 7, 2005 Washington, DC Raymond.

2005 AHIP Immunization Assessment Summary National Vaccine Advisory Committee November 29-30, 2005 Steve Black, MD, AHIP Liaison to NVAC Bob Rehm, Director.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair February 3, 2010.

Grantee Funding Status 44 th National Immunization Conference Atlanta, GA Lance E. Rodewald, MD Director, Immunization Services Division National Center.

A Vaccine Supply Update For The U.S. Market A Presentation At The National Vaccine Advisory Committee Meeting June 3, 2003 Dean Mason Chief, Program Support.

National Vaccine Advisory Committee A Status Report on the Pediatric Vaccine Stockpiles Pediatric Vaccine Stockpiles February 8, 2005 Eddie Wilder Project.

Vaccine University An Overview of the Vaccine Order Forecast Application (VOFA) Presented by Igor Bulim Public Health Analyst Vaccine Assurance and Safety.

Influenza Jeffrey S. Duchin, M.D. Chief, Communicable Disease Control, Epidemiology and Immunization Section, Public Health - Seattle & King County Division.

A Vaccine Supply Update For The U.S. Market A Presentation At National Advisory Committee Meeting February 4, 2003 Dean Mason Chief, Program Support Branch.

OVERVIEW OF THE NATIONAL INFLUENZA VACCINE SUMMIT Dennis J. O’Mara Associate Director for Adult Immunization Immunization Services Division National Immunization.

Planning for the Influenza Season National Vaccine Advisory Committee February 8, 2005 Washington, DC Lance E. Rodewald, MD Director, Immunization.

Non-institutionalized adults vaccinated annually against influenza and ever vaccinated against pneumococcal disease. Healthy Kansans 2010 Steering Committee.

Highlights of Recent Results from the New Health Insurance Modules of the National Immunization Survey National Vaccine Advisory Committee October 22,

Adult Immunization: Goals, Challenges, and a role for the National Vaccine Advisory Committee October 22, 2007 Raymond A. Strikas, MD National Vaccine.

CDC VACCINE STOCKPILE FISCAL AND MANAGEMENT ISSUES A Presentation At The National Vaccine Advisory Committee Meeting February 4, 2003 Kimberly S. Lane.

National Immunization Program (NIP)/Advisory Committee on Immunization Practices (ACIP) Report Stephen L. Cochi, MD, MPH Acting Director, National Immunization.

Carol Friedman, D.O. Associate Director for Adult Immunization Immunization Services Division National Center for Immunization and Respiratory Diseases.

SNIC, NIC Connecting the Connectors: Bringing Together Business Coalitions, Employers, Health Plans, Pediatricians and Public Health Pam Beal Southern.

Evaluation of the 2004 pneumococcal conjugate vaccine shortage utilizing data from the Michigan Childhood Immunization Registry Norma Allred, PhD, John.

2007 National Health Policy Conference Preparing to Protect: Flu Vaccines from Production to Consumption A Public Health Perspective Daniel Hopfensperger.

Welcome to the Immunization Requirements Webinar for Clinic Staff! For technical difficulties, call , press 1. During this webinar, everyone.

Some Perspectives on Vaccination of Adults

Georgia Immunization Rates

Improving Pediatric Immunization Rates In Children Under the Age of 3 in Two University Community Clinics Chad Alan Spain, MD Kyle Bradford Jones, MD.

Emerging Gaps in Financing for New Vaccines

Recommended Timeline for Influenza Vaccinations

Overview of Pandemic Influenza Planning Guide for SLTT

Texas Department of State Health Services Dr

What’s going on out there

2010 Tennessee Immunization Requirements for School Entrance:

School Vaccination Requirements

DSHS Adult Vaccine Program

Vaccine Financing Maria E. Volk, MPA

Contact: Anuradha Bhatt, MPH

Immunization in the Era of Health Reform: What’s Next?

Presentation transcript:

VFC Pediatric Vaccine Stockpile National Vaccine Advisory Committee October 23, 2007 Gregory S. Wallace, M.D., M.S., M.P.H. Chief, Vaccine Supply and Assurance Branch Immunization Services Division National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention

History of Vaccine Stockpile 1983 – 317 Grant-funded Stockpile (MMR, DT, DTwP, OPV, IPV) 1993 – VFC Legislation requirement for “6-month stockpile” > 20 million doses delivered

Current Stockpile Status (09/30/07)

VFC Stockpile Legislation Adequate Supply of Pediatric Vaccines to Meet Unanticipated Needs Negotiate for a 6-Month Supply Consider Potential for Outbreaks VFC Funded

Meet Unanticipated Needs VaccineDurationReasonResponse Td/TT11/00 – 6/02 (19 mos) GMP, leaving marketPriority for wound care DTaP3/01 – 7/02 (17 mos) GMP, preservative, leaving market Priorities based on provider supply MMR10/01 – 7/02 (10 mos) Manufacturing process updates Defer 2 nd doses if inadequate supply Varicella10/01 – 8/02 (11 mos) Manufacturing process updates Delay timing; prioritize if necessary PCV I8/01 – 5/03 (22 mos) Fill line problemsPriorities based on provider supply PCV II12/03 – 9/04 (10 mos) Fill line problems3-dose to 2-dose recommendation MCV4Summer ’05 & Summer ‘06 High DemandReinforce Recs to Defer y.o.

Negotiate a 6-Month Supply Changing Market and Recommendations Storage and Rotation Public Health Need May Vary by Vaccine − # of manufacturers − adequacy of temporary schedules − delays vs. shortage/failure

Consider Potential for Outbreaks Goal Different from Production Interruptions Combination Vaccines May Complicate Outbreak Response Should Specific Outbreak Response Stockpile be Included for Some Vaccines Should Vaccines with Low Outbreak Potential be Excluded

VFC Funded May Limit Flexibility of Vaccine − Borrowing Back for Non-VFC Eligible Populations − Previous Uses were with 317 Funded Vaccine Fully Funded ~ Annual CDC Vaccine Purchase (> $2 billion) Minimize Risk of Loss vs. Maximize Utility

CDC Work Group Staffed by CDC Disease Experts, Program Experts, and Economists Charge to the Work Group: 1) Evaluate/Re-scope Stockpile Vaccine Target Quantities 2) Identify Criteria for Establishing Targets 3) Identify Criteria for Vaccine Draw Downs (emergency and non-emergency) 4) Identify Criteria for Updates (periodic and otherwise)

Proposed NVAC Role Sounding Board for Difficult Options Discuss Options and Approaches Present Recommendations for External Review Provide Updates When Major Changes are Considered